Search Results

10 years' experience with the pneumococcal quinolone moxifloxacin

Authors: Burkhardt, Olaf; Welte, Tobias

Source: Expert Review of Anti-Infective Therapy, Volume 7, Number 6, August 2009 , pp. 645-668(24)

Publisher: Expert Reviews

Cost and clinical consequence of antibiotic non-adherence in acute exacerbations of chronic bronchitis [Review article]

Authors: Sorensen, S.V.; Baker, T.; Fleurence, R.; Dixon, J.; Roberts, C.; Haider, S.; Hughes, D.

Source: The International Journal of Tuberculosis and Lung Disease, Volume 13, Number 8, August 2009 , pp. 945-954(10)

Publisher: International Union Against Tuberculosis and Lung Disease

Treatment of acute bacterial exacerbations of chronic bronchitis

Authors: Siempos, Ilias I; Michalopoulos, Argyris; Falagas, Matthew E

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 7, May 2009 , pp. 1173-1182(10)

Publisher: Informa Healthcare

Chlamydophila pneumoniae

Authors: Blasi, F.; Tarsia, P.; Aliberti, S.

Source: Clinical Microbiology & Infection, Volume 15, Number 1, January 2009 , pp. 29-35(7)

Publisher: Blackwell Publishing

Prulifloxacin: clinical studies of a broad-spectrum quinolone agent

Authors: Giannarini, Gianluca; Tascini, Carlo; Selli, Cesare

Source: Future Microbiology, Volume 4, Number 1, February 2009 , pp. 13-24(12)

Publisher: Future Medicine

Procalcitonin as a biomarker of acute lower respiratory tract infections

Authors: Wróblewski, Tomasz; Marcisz, Czesław

Source: Expert Opinion on Medical Diagnostics, Volume 3, Number 1, January 2009 , pp. 67-79(13)

Publisher: Informa Healthcare

Moxifloxacin, levofloxacin costs compared at Chest 2008

Source: Inpharma, Volume 1, Number 1667, 2008-12-06 , pp. 7-7(1)

Publisher: Adis International

Moxifloxacin, levofloxacin costs compared at Chest 2008

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 568, 2008-12-13 , pp. 4-4(1)

Publisher: Adis International

A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin

Authors: Simoens, Steven; Decramer, Marc

Source: Expert Opinion on Pharmacotherapy, Volume 9, Number 10, July 2008 , pp. 1735-1744(10)

Publisher: Informa Healthcare

Moxifloxacin: a respiratory fluoroquinolone

Authors: Miravitlles, Marc; Anzueto, Antonio

Source: Expert Opinion on Pharmacotherapy, Volume 9, Number 10, July 2008 , pp. 1755-1772(18)

Publisher: Informa Healthcare

Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections

Authors: Hammerschlag, Margaret R; Sharma, Roopali

Source: Expert Opinion on Investigational Drugs, Volume 17, Number 3, March 2008 , pp. 387-400(14)

Publisher: Informa Healthcare

Faropenem Medoxomil: A0026, BAY 56-6854, BAY 566854, Faropenem Daloxate, SUN 208, SUN A0026

Author: Adis International Limited,

Source: Drugs in R&D, Volume 9, Number 2, 2008 , pp. 115-124(10)

Publisher: Adis International

Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease

Author: Moretti, Maurizio

Source: Expert Review of Respiratory Medicine, Volume 1, Number 3, December 2007 , pp. 307-316(10)

Publisher: Expert Reviews

Acute Exacerbations of Chronic Bronchitis in Elderly Patients: Pathogenesis, Diagnosis and Management

Authors: Don Hayes Jr,; Meyer, Keith C.

Source: Drugs & Aging, Volume 24, Number 7, 2007 , pp. 555-572(18)

Publisher: Adis International

Antimicrobials comparable for chronic bronchitis

Source: Inpharma, Volume 1, Number 1598, 2007-07-28 , pp. 10-10(1)

Publisher: Adis International

Antibiotic treatment for patients with acute exacerbations of chronic bronchitis

Authors: Pacios, E.; Gestoso, I.; Villarroel, P.

Source: Clinical Microbiology & Infection, Volume 13, Number 7, July 2007 , pp. 747-748(2)

Publisher: Blackwell Publishing

Evaluation of real-time PCR for the detection and quantification of bacteria in chronic obstructive pulmonary disease

Authors: Curran, Tanya; Coyle, Peter V.; McManus, Terence E.; Kidney, Joe; Coulter, Wilson A.

Source: FEMS Immunology & Medical Microbiology, Volume 50, Number 1, June 2007 , pp. 112-118(7)

Publisher: Blackwell Publishing

Faropenem: review of a new oral penem

Authors: Schurek, Kristen N; Wiebe, Ryan; Karlowsky, James A; Rubinstein, Ethan; Hoban, Daryl J; Zhanel, George G

Source: Expert Review of Anti-Infective Therapy, Volume 5, Number 2, April 2007 , pp. 185-198(14)

Publisher: Expert Reviews

Pharmacoeconomics of the management of acute exacerbations of chronic obstructive pulmonary disease

Authors: Simoens, Steven; Decramer, Marc

Source: Expert Opinion on Pharmacotherapy, Volume 8, Number 5, April 2007 , pp. 633-648(16)

Publisher: Informa Healthcare

Abbott Canada has launched the fluoroquinolone gemifloxacin [Factive] for the 5-day treatment of acute bacterial exacerbations of chronic bronchitis

Source: Inpharma, Volume 1, Number 1578, 2007-03-10 , pp. 23-23(1)

Publisher: Adis International